| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Addicted to proteostasis: How KRAS-driven cancers acquire resistance to clinical KRAS inhibitors
|
Klein, Austin T.
|
|
|
30 |
11 |
p. 1334-1336
|
article
|
| 2 |
Anti-tumor effect of PD-L1-targeting antagonistic aptamer-ASO delivery system with dual inhibitory function in immunotherapy
|
Luo, Fatao
|
|
|
30 |
11 |
p. 1390-1401.e6
|
article
|
| 3 |
Arabinose- and xylose-modified analogs of 2′,3′-cGAMP act as STING agonists
|
Xie, Wei
|
|
|
30 |
11 |
p. 1366-1376.e7
|
article
|
| 4 |
Come for the atmosphere, stay for the interactions: Deciphering small molecule partitioning into biomolecular condensates
|
Sepehri, Bakhtyar
|
|
|
30 |
11 |
p. 1337-1339
|
article
|
| 5 |
CryoEM structures of adhesion in GPCR CD97: Filling in some of the gaps
|
Krumm, Brian E.
|
|
|
30 |
11 |
p. 1327-1329
|
article
|
| 6 |
Enabling inclusion and looking ahead
|
Dey, Mishtu
|
|
|
30 |
11 |
p. 1323
|
article
|
| 7 |
Fine-tuning chemical genetics to identify physiologic drug targets
|
Vostal, Lauren E.
|
|
|
30 |
11 |
p. 1331-1333
|
article
|
| 8 |
Genetically incorporated crosslinkers identify regulators of membrane protein PD-L1 in mammalian cells
|
Chai, Fangni
|
|
|
30 |
11 |
p. 1488-1497.e5
|
article
|
| 9 |
HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation
|
Xiao, Yufeng
|
|
|
30 |
11 |
p. 1421-1435.e12
|
article
|
| 10 |
Inducible mismatch repair streamlines forward genetic approaches to target identification of cytotoxic small molecules
|
Nguyen, Thu P.
|
|
|
30 |
11 |
p. 1453-1467.e8
|
article
|
| 11 |
In vivo bioluminescence imaging of labile iron in xenograft models and liver using FeAL-1, an iron-activatable form of D-luciferin
|
Gonciarz, Ryan L.
|
|
|
30 |
11 |
p. 1468-1477.e6
|
article
|
| 12 |
Mechanism-based inhibition of gut microbial tryptophanases reduces serum indoxyl sulfate
|
Graboski, Amanda L.
|
|
|
30 |
11 |
p. 1402-1413.e7
|
article
|
| 13 |
Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cells
|
Keitany, Gladys J.
|
|
|
30 |
11 |
p. 1377-1389.e8
|
article
|
| 14 |
New advisory board members speak on challenges and opportunities in chemical biology
|
Li, Xiang David
|
|
|
30 |
11 |
p. 1324-1326
|
article
|
| 15 |
Protomer selectivity of type II RAF inhibitors within the RAS/RAF complex
|
Vasta, James D.
|
|
|
30 |
11 |
p. 1354-1365.e6
|
article
|
| 16 |
Raf protomers: Drug binding preferences in living cells
|
Dalby, Kevin N.
|
|
|
30 |
11 |
p. 1329-1331
|
article
|
| 17 |
Structural basis of CD97 activation and G-protein coupling
|
Wang, Na
|
|
|
30 |
11 |
p. 1343-1353.e5
|
article
|
| 18 |
Target deconvolution with matrix-augmented pooling strategy reveals cell-specific drug-protein interactions
|
Ji, Hongchao
|
|
|
30 |
11 |
p. 1478-1487.e7
|
article
|
| 19 |
Targeted kinase degradation via the KLHDC2 ubiquitin E3 ligase
|
Kim, Younghoon
|
|
|
30 |
11 |
p. 1414-1420.e5
|
article
|
| 20 |
Tracking neurodegenerative diseases in biofluids: Combining pathology and pathophysiology markers is the way
|
Mastrangelo, Andrea
|
|
|
30 |
11 |
p. 1340-1342
|
article
|
| 21 |
USP10 strikes down β-catenin by dual-wielding deubiquitinase activity and phase separation potential
|
Wang, Yinuo
|
|
|
30 |
11 |
p. 1436-1452.e10
|
article
|
Journal description